Japan Retinal Disorder Treatment Market Size & Outlook
Japan retinal disorder treatment market, 2018-2030 (US$M)
Related Markets
Japan retinal disorder treatment market highlights
- The Japan retinal disorder treatment market generated a revenue of USD 744.6 million in 2023 and is expected to reach USD 1,446.4 million by 2030.
- The Japan market is expected to grow at a CAGR of 10% from 2024 to 2030.
- In terms of segment, macular degeneration was the largest revenue generating type in 2023.
- Diabetic Retinopathy is the most lucrative type segment registering the fastest growth during the forecast period.
Retinal disorder treatment market data book summary
| Market revenue in 2023 | USD 744.6 million |
| Market revenue in 2030 | USD 1,446.4 million |
| Growth rate | 10% (CAGR from 2023 to 2030) |
| Largest segment | Macular degeneration |
| Fastest growing segment | Diabetic Retinopathy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetic Retinopathy, Other Types, Macular Degeneration |
| Key market players worldwide | Santen Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, GrayBug, Takeda Pharmaceutical Co Ltd, Bayer AG, AbbVie Inc, Roche Holding AG ADR, Acucela, Pfizer Inc, Kubota Pharmaceutical Holdings |
Other key industry trends
- In terms of revenue, Japan accounted for 5.4% of the global retinal disorder treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan retinal disorder treatment market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 666.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Retinal Disorder Treatment Market Scope
Retinal Disorder Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan retinal disorder treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to retinal disorder treatment market will help companies and investors design strategic landscapes.
Macular degeneration was the largest segment with a revenue share of 44.23% in 2023. Horizon Databook has segmented the Japan retinal disorder treatment market based on diabetic retinopathy, other types, macular degeneration covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Japan retinal disorder treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan retinal disorder treatment market databook
-
Our clientele includes a mix of retinal disorder treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan retinal disorder treatment market, including forecasts for subscribers. This country databook contains high-level insights into Japan retinal disorder treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan retinal disorder treatment market size, by type, 2018-2030 (US$M)
Japan Retinal Disorder Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
